Description
Ovagen is a short-chain peptide bioregulator marketed within the Khavinson cytomedin / cytogen peptide tradition — a class of low molecular weight peptide compounds proposed to function through tissue-specific gene expression modulation. Unlike the major characterized Khavinson peptides (Epithalon, Cortagen, Pinealon, Chonluten) which have defined sequences published in the Russian academic literature, Ovagen is a less rigorously characterized peptide preparation described as ovarian tissue-derived. The compound is investigated in preclinical research as a representative of the broader peptide bioregulator class for tissue-specific short-peptide pharmacology research and is studied alongside other cytomedin-class compounds in comparative Khavinson SAR investigations. Because the specific sequence of “Ovagen” is not well-documented in published Western scientific literature, researchers working with this compound should verify the specific chemistry against the supplier’s Certificate of Analysis (COA) and rely on the MS-verified molecular weight as the primary identity confirmation.
Benefits (Research Focus)
• Khavinson cytomedin class research — studied as a representative compound for tissue-specific peptide bioregulator pharmacology
• Reproductive cell biology — investigated for gene expression endpoints in reproductive tissue research models
• Comparative SAR research — explored alongside other Khavinson short-peptide bioregulators for structure-activity studies
• Cellular signaling research — examined for tissue-selective peptide bioregulator effects in cell culture models
• Geroscience research — researched for cellular aging endpoints in reproductive tissue research
What Researchers Look At
• Gene expression patterns in reproductive cell line research models
• Cellular proliferation and viability markers in ovarian cell culture systems
• Comparative pharmacology versus characterized Khavinson peptides (Epithalon, Cortagen, etc.)
• Molecular weight characterization and MS-based identity verification (chemistry not publicly defined)
• Tissue-selective uptake and downstream signaling in research models
Quick Specs
• Form: Lyophilized white powder
• Net Peptide Content: 20 mg per vial
• Quantity: 1 vial
• Appearance: White to off-white lyophilizate
• Reconstitution: Bacteriostatic or sterile water (added by the end researcher)
• Purity: ≥99% by HPLC
• Identity: MS-verified (per COA)
• Storage: Protect from light
Identity Basics
• Compound: Ovagen
• Synonyms: Ovarian peptide bioregulator; Khavinson-tradition ovarian cytomedin
• Class: Short-chain peptide bioregulator; Khavinson-tradition cytomedin / cytogen class
• Sequence: Not publicly characterized in Western scientific literature (verify against batch COA)
• Molecular Weight: Low molecular weight peptide fraction, reported in the ~400–600 Da range (verify against batch COA)
• CAS: Not formally assigned (peptide bioregulator class without defined chemistry)
⚠️ Disclaimer
- This product is intended for laboratory research use only.
- Not for human or veterinary use.
- Not approved for diagnostic, therapeutic, or medical applications.
- Handle using appropriate laboratory safety procedures and personal protective equipment.
COA Verification Notice: Even if the vial label or product image states a certain concentration, always go by the COA for the true verified value. We reference the COA to determine the verified concentration and purity of each product, regardless of what the label or product image indicates.
Janoshik COA — Third-Party Testing
